"The Rheumatic Disease Center is committed to providing quality patient centered care, education and research. We strive to be a center of excellence in rheumatology by delivering outstanding service in a kind considerate manner taking into account each patient’s unique needs. Our guiding principles are quality, service and respect for all."

During the past decade, Rheumatic Disease Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 10 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheumatic Disease Center" #1 sponsor was "Bristol-Myers Squibb" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Human Genome Sciences Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumatic Disease Center" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Rheumatic Disease Center" are "Rheumatoid Arthritis" (12 trials), "Arthritis, Rheumatoid" (2 trials), "Gout" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Dermatomyositis" (1 trials). Many other conditions were trialed in "Rheumatic Disease Center" in a lesser frequency.

Most popular intervention types in "Rheumatic Disease Center" are "Drug" (18 trials), "Biological" (4 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Methotrexate" (4 trials), "Abatacept" (3 trials), "Baricitinib" (3 trials) and "Adalimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rheumatic Disease Center" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Rheumatic Disease Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Rheumatic Disease Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Rheumatic Disease Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".